Also trades as: BTMDW (OTC)
BTMD NASDAQ
biote Corp.
1W: -10.0%
1M: -11.6%
3M: -4.3%
YTD: -19.8%
1Y: -51.7%
3Y: -66.5%
5Y: -80.4%
$2.10
+0.12 (+6.33%)
Weekly Expected Move ±6.6%
$2
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$87.1M
52W Range1.27-4.75
Volume256,747
Avg Volume256,470
Beta1.71
Dividend—
Analyst Ratings
Company Info
CEOBret Christensen
Employees217
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2021-04-28
Websitebiote.com
1875 West Walnut Hill Lane
Irving, TX 75038
US
Irving, TX 75038
US
844-604-1246
About biote Corp.
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| HEYER ANDREW R | A-Award | 130,000 | $2.20 | 2026-05-12 |
| HEYER ANDREW R | A-Award | 35,259 | — | 2026-05-12 |
| MORRIS DEBRA L | A-Award | 130,000 | $2.20 | 2026-05-12 |
| MORRIS DEBRA L | M-Exempt | 21,407 | — | 2026-05-12 |
| MORRIS DEBRA L | A-Award | 39,036 | — | 2026-05-12 |